Chinese researchers to test double doses of CanSino's coronavirus vaccine candidate
BEIJING (Reuters) - Researchers plan to start a clinical trial for an additional dose of a coronavirus vaccine candidate co-developed by China's CanSino Biologics Inc and a military-backed research unit, clinical trial registry data showed.
Japan sending team to probe Mauritius ship grounding
TOKYO (Reuters) - Japan said on Friday it will send a five-person team to Mauritius to investigate the grounding of a Japanese-owned ship off the country's coast that led to an environmental crisis.
CORRECTED-UPDATE 1-Taiwan conservationists say kicked out of global bird group in China row
TAIPEI, Sept 15 (Reuters) - A Taiwan conservation group said on Tuesday it had been kicked out of a British-based wild bird protection body after it had been asked and refused to sign a document stating it did not advocate for the Chinese-claimed island's independence.
U.S. CDC testing guidance was published against scientists' objections: NYT
(Reuters) - Guidance about novel coronavirus testing posted last month on the website of the U.S. Centers for Disease Control and Prevention (CDC) was not written by the agency's scientists and was posted over their objections, the New York Times reported citing people familiar with the matter and internal documents.
British bird group issues gag order over Taiwan-China issue
TAIPEI (Reuters) - A British-based wild bird body has issued a gag order telling employees not to comment on its decision to expel a Taiwan conservation group that refused to sign a document related to the Chinese-claimed island's political position.
Firefighters make headway in subduing U.S. western wildfires
MOLALLA, Ore. (Reuters) - Crews who struggled just days ago against deadly wildfires raging unchecked across California, Oregon and Washington have now taken the offensive, making substantial progress in subduing the blazes, officials in all three states said on Thursday.
U.S. CDC testing guidance was published against scientists' objections -NYT
Sept 17 (Reuters) - Guidance about novel coronavirus testing posted last month on the website of the U.S. Centers for Disease Control and Prevention (CDC) was not written by the agency's scientists and was posted over their objections, the New York Times reported citing people familiar with the matter and internal documents.
Explainer: When will COVID-19 vaccines be generally available in the U.S.?
(Reuters) - U.S. President Donald Trump and the head of the Centers for Disease Control and Prevention (CDC) on Wednesday disagreed about when a COVID-19 vaccine would become widely available. Trump has said one could initially be available by the Nov. 3 election, while the CDC director said vaccines were likely to reach the general public around mid-2021, an assessment more in line with most experts.
U.S. plans for hundreds of millions of cheap, fast COVID-19 tests
(Reuters) - U.S. manufacturers are sharply increasing production of cheap, fast - but less accurate - COVID-19 tests, aiming for 100 million per month by year end that will enable schools and workplaces to significantly expand testing.
U.S. shelves Wyoming oil and gas leasing plans over sage grouse
(Reuters) - The Trump administration has shelved plans to offer nearly 350,000 acres for oil and gas leasing in Wyoming next week, according to documents seen by Reuters on Thursday, citing protections for a threatened Western bird.
- More Science Headlines»